USPTO serial 79428897
FILLUNAR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 2, 2026
- Examiner
- NANNEY, KATHERINE N
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with FILLUNAR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Antiseptic preparations; medical hyaluronic acid in ampoule form for pharmaceutical purposes; drug delivery agents in the form of lyophilized formulations that facilitate the delivery of pharmaceutical preparations for the treatment of facial wrinkles and volume enhancement; medical preparations for the treatment of skin wrinkles and facial volume loss using drug delivery systems; chemical preparations for pharmaceutical use, namely, for skin wrinkles and facial volume loss using drug delivery systems; cells for medical purposes; reagents for medical use; pharmaceutical preparations for the treatment of skin wrinkles and facial volume loss using drug delivery systems; diagnostic preparations for medical purposes; medical anti-aging serum; viscous fillers for wrinkle filling or volume augmentation being medical skin grafts; nucleic acid for medical purposes; medical hyaluronic acid preparations for pharmaceutical purposes; pharmaceutical skin lotions; pharmaceutical preparations for skin wrinkles and facial volume loss using drug delivery systems; surgical transplants comprising living tissues; pharmaceutical preparations for the treatment and prevention of skin wrinkles and facial volume loss using drug delivery systems; natural biomaterials for tissue recovery for medical purposes; pharmaceutical preparations for the treatment of wrinkles; injectable medical preparations for wrinkle filling in the form of gels; injectable dermal fillers for the treatment of wrinkles in the form of gels; injectable dermal fillers; injectable pharmaceuticals for treatment of skin wrinkles and facial volume loss using drug delivery systems; injectable dermal fillers for the treatment of forehead lines, glabellar lines, temple lines, cheek volume loss, cheekbone volume loss, nasolabial folds lines, marionette lines, lip lines; pharmaceutical preparation for skin care; bandages for skin wounds; pharmaceutical preparation for scar treatment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 2, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 2, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 14, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 14, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 8, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 18, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 18, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 18, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 18, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 9, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 9, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 9, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 7, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 7, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 7, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 5, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 20, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 20, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 2, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 1, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 25, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 5, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 5, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 31, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |